You can tune in to a live broadcast tomorrow on the Colorado Life Science Deal Flow blog, featuring Mike Bristow, M.D., Ph.D., founder of Myogen, speaking about the company’s history from inception to exit.
Dr. Bristow was the principal founder, chief science & medical officer and director of Myogen. In November of 2006 Gilead acquired Myogen for $52.50/share or $2.5 billion! Dr. Bristow is Professor of Medicine and the former Head of Cardiology at the University of Colorado Health Sciences Center, the Co-Director of the Colorado Cardiovascular Institute and is presently founder, chair and CSMO of ARCA Discovery.
March 7, 2007